280 related articles for article (PubMed ID: 25531332)
1. NCOA3-mediated upregulation of mucin expression via transcriptional and post-translational changes during the development of pancreatic cancer.
Kumar S; Das S; Rachagani S; Kaur S; Joshi S; Johansson SL; Ponnusamy MP; Jain M; Batra SK
Oncogene; 2015 Sep; 34(37):4879-89. PubMed ID: 25531332
[TBL] [Abstract][Full Text] [Related]
2. The mucin MUC4 is a transcriptional and post-transcriptional target of K-ras oncogene in pancreatic cancer. Implication of MAPK/AP-1, NF-κB and RalB signaling pathways.
Vasseur R; Skrypek N; Duchêne B; Renaud F; Martínez-Maqueda D; Vincent A; Porchet N; Van Seuningen I; Jonckheere N
Biochim Biophys Acta; 2015 Dec; 1849(12):1375-84. PubMed ID: 26477488
[TBL] [Abstract][Full Text] [Related]
3. Significance of mucin expression in pancreatobiliary neoplasms.
Yonezawa S; Higashi M; Yamada N; Yokoyama S; Goto M
J Hepatobiliary Pancreat Sci; 2010 Mar; 17(2):108-24. PubMed ID: 19787286
[TBL] [Abstract][Full Text] [Related]
4. Nicotine/cigarette smoke promotes metastasis of pancreatic cancer through α7nAChR-mediated MUC4 upregulation.
Momi N; Ponnusamy MP; Kaur S; Rachagani S; Kunigal SS; Chellappan S; Ouellette MM; Batra SK
Oncogene; 2013 Mar; 32(11):1384-95. PubMed ID: 22614008
[TBL] [Abstract][Full Text] [Related]
5. Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy.
Rachagani S; Torres MP; Kumar S; Haridas D; Baine M; Macha MA; Kaur S; Ponnusamy MP; Dey P; Seshacharyulu P; Johansson SL; Jain M; Wagner KU; Batra SK
J Hematol Oncol; 2012 Oct; 5():68. PubMed ID: 23102107
[TBL] [Abstract][Full Text] [Related]
6. The canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinoma.
Pai P; Rachagani S; Lakshmanan I; Macha MA; Sheinin Y; Smith LM; Ponnusamy MP; Batra SK
Mol Oncol; 2016 Feb; 10(2):224-39. PubMed ID: 26526617
[TBL] [Abstract][Full Text] [Related]
7. Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas.
Yokoyama S; Higashi M; Kitamoto S; Oeldorf M; Knippschild U; Kornmann M; Maemura K; Kurahara H; Wiest E; Hamada T; Kitazono I; Goto Y; Tasaki T; Hiraki T; Hatanaka K; Mataki Y; Taguchi H; Hashimoto S; Batra SK; Tanimoto A; Yonezawa S; Hollingsworth MA
Oncotarget; 2016 Jul; 7(27):42553-42565. PubMed ID: 27283771
[TBL] [Abstract][Full Text] [Related]
8. Acinar transformed ductal cells exhibit differential mucin expression in a tamoxifen-induced pancreatic ductal adenocarcinoma mouse model.
Mallya K; Haridas D; Seshacharyulu P; Pothuraju R; Junker WM; Krishn SR; Muniyan S; Vengoji R; Batra SK; Rachagani S
Biol Open; 2020 Sep; 9(9):. PubMed ID: 32709695
[TBL] [Abstract][Full Text] [Related]
9. MUC4 expression is regulated by cystic fibrosis transmembrane conductance regulator in pancreatic adenocarcinoma cells via transcriptional and post-translational mechanisms.
Singh AP; Chauhan SC; Andrianifahanana M; Moniaux N; Meza JL; Copin MC; van Seuningen I; Hollingsworth MA; Aubert JP; Batra SK
Oncogene; 2007 Jan; 26(1):30-41. PubMed ID: 16799633
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-induced oxidative stress promotes MUC4 degradation via autophagy to enhance pancreatic cancer cells survival.
Joshi S; Kumar S; Ponnusamy MP; Batra SK
Oncogene; 2016 Nov; 35(45):5882-5892. PubMed ID: 27109098
[TBL] [Abstract][Full Text] [Related]
11. The antagonistic regulation of human MUC4 and ErbB-2 genes by the Ets protein PEA3 in pancreatic cancer cells: implications for the proliferation/differentiation balance in the cells.
Fauquette V; Perrais M; Cerulis S; Jonckheere N; Ducourouble MP; Aubert JP; Pigny P; Van Seuningen I
Biochem J; 2005 Feb; 386(Pt 1):35-45. PubMed ID: 15461591
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of mucins 1-6 in papillary thyroid carcinoma: evidence for transformation-dependent post-translational modifications of MUC1 in situ.
Magro G; Schiappacassi M; Perissinotto D; Corsaro A; Borghese C; Belfiore A; Colombatti A; Grasso S; Botti C; Bombardieri E; Perris R
J Pathol; 2003 Jul; 200(3):357-69. PubMed ID: 12845632
[TBL] [Abstract][Full Text] [Related]
13. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance.
Andrianifahanana M; Moniaux N; Schmied BM; Ringel J; Friess H; Hollingsworth MA; Büchler MW; Aubert JP; Batra SK
Clin Cancer Res; 2001 Dec; 7(12):4033-40. PubMed ID: 11751498
[TBL] [Abstract][Full Text] [Related]
14. Synergistic induction of the MUC4 mucin gene by interferon-gamma and retinoic acid in human pancreatic tumour cells involves a reprogramming of signalling pathways.
Andrianifahanana M; Agrawal A; Singh AP; Moniaux N; van Seuningen I; Aubert JP; Meza J; Batra SK
Oncogene; 2005 Sep; 24(40):6143-54. PubMed ID: 16007204
[TBL] [Abstract][Full Text] [Related]
15. Effects of RNAi-mediated MUC4 gene silencing on the proliferation and migration of human pancreatic carcinoma BxPC-3 cells.
Li Y; Wu C; Chen T; Zhang J; Liu G; Pu Y; Zhu J; Shen C; Zhang Y; Zeng N; Zhang X
Oncol Rep; 2016 Dec; 36(6):3449-3455. PubMed ID: 27748843
[TBL] [Abstract][Full Text] [Related]
16. Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells.
Lakshmanan I; Seshacharyulu P; Haridas D; Rachagani S; Gupta S; Joshi S; Guda C; Yan Y; Jain M; Ganti AK; Ponnusamy MP; Batra SK
Oncotarget; 2015 Aug; 6(25):21085-99. PubMed ID: 26035354
[TBL] [Abstract][Full Text] [Related]
17. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins.
Chaturvedi P; Singh AP; Moniaux N; Senapati S; Chakraborty S; Meza JL; Batra SK
Mol Cancer Res; 2007 Apr; 5(4):309-20. PubMed ID: 17406026
[TBL] [Abstract][Full Text] [Related]
18. IFN-gamma-induced expression of MUC4 in pancreatic cancer cells is mediated by STAT-1 upregulation: a novel mechanism for IFN-gamma response.
Andrianifahanana M; Singh AP; Nemos C; Ponnusamy MP; Moniaux N; Mehta PP; Varshney GC; Batra SK
Oncogene; 2007 Nov; 26(51):7251-61. PubMed ID: 17525742
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of transmembrane mucins, MUC1 and MUC4, in human prostate carcinomas.
Singh AP; Chauhan SC; Bafna S; Johansson SL; Smith LM; Moniaux N; Lin MF; Batra SK
Prostate; 2006 Mar; 66(4):421-9. PubMed ID: 16302265
[TBL] [Abstract][Full Text] [Related]
20. Axed MUC4 (MUC4/X) aggravates pancreatic malignant phenotype by activating integrin-β1/FAK/ERK pathway.
Jahan R; Macha MA; Rachagani S; Das S; Smith LM; Kaur S; Batra SK
Biochim Biophys Acta Mol Basis Dis; 2018 Aug; 1864(8):2538-2549. PubMed ID: 29777904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
